cutting edge of research and science annual report on ... 2013... · annual report on technology...

7
THE UNIVERSITY OF TOLEDO ANNUAL REPORT ON TECHNOLOGY TRANSFER 2013 FISCAL YEAR Technology Transfer The process of transferring creations, discoveries and innovations resulting from university research to the commercial sector. Cutting Edge of Research and Science

Upload: others

Post on 02-Jun-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Cutting Edge of Research and Science ANNUAL REPORT ON ... 2013... · ANNUAL REPORT ON TECHNOLOGY TRANSFERFISCAL YEAR2013 Technology Transfer The process of transferring creations,

T H E U N I V ERS I T Y OF TOL EDO A N N U A L R E P O RT O N T E C H N O LO G Y T R A N S F E R

2013F I SC A L Y E A R

Technology TransferThe process of transferring creations, discoveries and innovations resulting from university research to the commercial sector.

Cutting Edge of Research and Science

Page 2: Cutting Edge of Research and Science ANNUAL REPORT ON ... 2013... · ANNUAL REPORT ON TECHNOLOGY TRANSFERFISCAL YEAR2013 Technology Transfer The process of transferring creations,

The University of Toledo (UT) technology transfer team provides professional services to faculty, staff and students as they pursue development of commercializable innovations that create new jobs and economic growth for the local community and the world beyond.

The team’s primary duty is to smoothly facilitate the transfer of UT-developed creations, discoveries and innovations to the marketplace. They do this by guiding inventors through the intricate process of protecting and licensing their intellectual property, identifying and helping to secure funding including grants and sponsored research opportunities for further development, and working with inventors to help their platform technologies move toward becoming successful University spin-off businesses.

Other functions of the technology transfer team include:

• Assisting inventors with completing and submitting invention disclosure forms

• Analyzing commercial potential of creations, discoveries and innovations

• Obtaining protection for intellectual property and marketing technologies to potential licensees

• Preparing and executing agreements including confidentiality, material transfer, industry sponsored

research, inter-institutional, memoranda of understanding, and licenses

• Developing and maintaining relationships with industry to receive feedback quickly

on new technologies and/or execute agreements

Translating UT research into commercial success

The numbers tell the story

21 Medicine & Life Sciences

39 Engineering

8 Pharmacy

14 NSM

2 CCI

1 IT

2 EDU

2 UTMC 1 LLSS

INVENTION DISCLOSURES BY COLLEGE FY2013 TECHNOLOGY TRANSFER METRICS

Agreements Processed

Licenses and Options

Licensing Revenue

Invention Disclosures

It is commonly known that state and national funding opportunities are available to academic researchers for basic research. What is not as well known is that the latest trend from some of these funding sources is a requirement that the technology possesses strong intellectual property that can be validated as commercially valuable with the potential of adding to economic growth in the form of new technology-based products that will form the basis of start-up companies and new jobs.

Ohio Opportunities: The Third Frontier Technology Validation and Start-Up Fund (TVSF) is one way in which UT’s Technology Transfer Office collaborates with faculty inventors. The fund is offered for two different phases of development and is available on a periodic basis to Ohio institutions of higher education and start-up companies that have licensed intellectual property (IP) from those institutions. Phase 1 provides up to $50,000 from the fund plus 1:1 matching funds from the institution to help researchers generate proof needed to move the technology to the point that it is ready to be licensed by an Ohio start-up company or deemed unfeasible for commercialization. The funding pays for validation activities such as prototyping, demonstrations and assessment of critical failure points in subsequent development, scale-up, and commercialization. Phase 2 provides up to $100,000 for start-up companies that have licensed IP developed at Ohio research institutions during the critical early life of the company to help accelerate the time to market.

Since its inception in January 2012, more than $800,000 has been awarded to

UT inventors and start-ups from TVSF and matching funds to support development of commercializable products and processes. In fact, UT has claimed nine TVSF grants — second only to The Ohio State University

with a total of 12. The other 26 awards granted thus far were divided among 13

other Ohio universities.

Looking for research funding?

Other Funding: National Science Foundation (NSF) I-Corps grants are another good source of funding. The fund was created to develop and nurture a national innovation ecosystem by helping discoveries from fundamental research become new technologies that benefit society. Since that program’s inception in July 2011, UT faculty members Drs. Vijay Devabhaktuni, Mohammad Elahinia, Champa Jayasuriya, Rashmi Jha and Ashok Kumar have received five of 11 such grants awarded to Ohio inventors.

Inventors wishing to apply for TVSF or NSF I-Corps funding are invited to contact Anne Izzi in the Technology Transfer Office at 419.530.6226 or [email protected] to learn how we may be able to help secure funding.

Page 3: Cutting Edge of Research and Science ANNUAL REPORT ON ... 2013... · ANNUAL REPORT ON TECHNOLOGY TRANSFERFISCAL YEAR2013 Technology Transfer The process of transferring creations,

BIOENGINEERING

PLASMONIC-BASED BIOMARKER SENSING TECHNOLOGYThis technology, developed by Dr. Brent Cameron and Dr. Dong-Shik Kim, is a two-part process that allows for the rapid prototyping of surface plasmon resonance (SPR) sensors that are customizable toward almost any available biomarker. The first product planned for commercialization is expected to be a portable handheld sensor, capable of providing low-cost ultra-accurate glycemic compliance assessment for the diabetes market. In addition, the technology will allow multiple biomarkers to be analyzed in a single bio-sample through an image-based measurement. In this case, by using a single patient sample (i.e. saliva, serum, etc.), a detailed analysis and screening for numerous biomarkers occurs simultaneously. Based upon existing testing, it is anticipated that this technology will provide comparable performance to established clinical/lab-based technology, but in a handheld package and will be available at a fraction of the cost.

MECHANICAL, INDUSTRIAL AND

MANUFACTURING ENGINEERING (MIME)INJECTABLE BONE CEMENT Dr. Sarit Bhaduri and his team have developed an injectable calcium phosphate-based (Ca-P) bone cement which can be easily manipulated and avoids problems inherent in currently available products. This new compound is a robust and unique composition and requires only one solid ingredient as compared to two in other products. The unique formulation of the cement allows it to flow

smoothly and homogeneously and results in uniform resorption and increased strength with improved injectability and cohesiveness. In addition, the product provides optimum viscosity and smoother flow and solves the difficulties of measuring and mixing ingredients as required with other products.

BIOENGINEERING

FACET FIXATION SCREWDr. Vijay Goel and Dr. Anand Agarwal have developed a minimally-invasive spinal fixation system, allowing for a small incision and a minimal morbidity approach to provide a solution for spinal stenosis. The system possesses a major competitive edge because it delivers bone through the use of bridging technology without an additional procedure and without compromising the stability of the fixation. The technology harnesses the bone without use of a rod, and allows more flexible motion than a rigid screw/rod construct with no loosening of the facet screw. In addition, a solid locking implant and fusion prevent further slippage and facet joint pain. The patient experiences a shorter, minimally-invasive procedure with faster recovery time and no clinical compromise. This translates to shorter hospital stays, improved clinical outcome and cost effectiveness.

CONGRATULATIONS!UT’s successful Ohio Third Frontier grant recipients

MECHANICAL, INDUSTRIAL AND MANUFACTURING

ENGINEERING (MIME)/COLLEGE OF MEDICINE

AND LIFE SCIENCES

PERCUTANEOUS MECHANICAL THROMBECTOMY DEVICEA team led by Dr. Mohammad Elahinia and Dr. Christopher Cooper has developed a minimally-invasive cardiovascular device that removes blood clots and reduces the risk of secondary clot formation along with the associated complications and fatalities. The prototype device uses a pair of superelastic nitinol elements to aid in the collection of a thrombus and minimize distal embolization. One of the key advantages of this device over others is the use of a guidance funnel which helps to evacuate pieces of thrombus without shearing the clot into smaller pieces. Based upon initial in vitro testing, the prototype device shows superior performance to existing clot control devices in reducing the number of small blood clots that are produced during the removal of the main clot. The technology also has applications to a wide range of other nitinol-based cardiovascular devices.

BIOENGINEERING/CHEMICAL ENGINEERING

NANO-BIOSENSOR FOR INFECTION IN TISSUEThis novel biosensor developed by Dr. Anand Agarwal and Dr. Dong-Shik Kim is extremely adaptable and may be designed to detect any specific bacteria that may cause infection in bone structure. Pathogens to be detected include but are not limited to methicillin-resistant Staphyloccus aureus (MRSA) and Escherichia coli (E. coli) which are common sources of post-surgical infection. In

fact, the biosensor can be designed to detect any gram-positive or gram-negative bacteria and rapidly differentiate between the two, providing immediate results to surgeons during surgery, thus greatly reducing or eliminating complications of infection during the post-surgery period.

CHEMICAL ENGINEERING/CIVIL ENGINEERING

NON-TOXIC ANTIBACTERIAL SURFACTANT/MICROGEL FORMULATIONSDr. Yakov Lapitsky and Dr. Youngwoo Seo have developed novel formulations of microgels that are instrumental in preparing antibacterial mixtures for use in cleaning and personal care products. These microgel dispersions mixed with non-toxic materials may be substituted for commonly used toxic antibacterial agents including triclosan or bleach. These microgels exhibit high antimicrobial activity even at very low concentrations, allowing for rapid killing of large numbers of microbes upon contact without damaging the surface. In addition, these formulations dissolve easily at neutral and alkaline pH levels making the biopolymer even more versatile.

UT ENGINEERING CENTER FOR ORTHOPAEDIC RESEARCH

NEXT GENERATION SPINAL IMPLANTSAssisted by the technology transfer team, Drs. Vijay Goel, Sarit Bhaduri and Anand Agarwal with UT’s Engineering Center for Orthopaedic Research Excellence (E-CORE) recently secured a $2.4 million Innovation Platform Program grant to develop several next generation spinal implants and a therapeutic device from concept to market entry.

Page 4: Cutting Edge of Research and Science ANNUAL REPORT ON ... 2013... · ANNUAL REPORT ON TECHNOLOGY TRANSFERFISCAL YEAR2013 Technology Transfer The process of transferring creations,

Experience + Creativity = Lab-to-Launch The University of Toledo’s Lab-to-Launch program encourages and enables faculty start-up businesses

that can contribute to local and regional economic development. The progressive program is tightly

coordinated and orchestrated to move the highest potential business opportunities from the laboratory

bench to commercial launch as quickly and efficiently as possible.

Our team works closely with faculty inventors to identify potentially valuable commercial opportunities

and connects them with regional economic development organizations, including Innovation

Enterprises (IE) at The University of Toledo, Rocket Ventures (RV) and the Regional Growth Partnership.

These organizations review the technology and business plan and provide services such as

management consulting as well as funding for proof-of-concept and further development to new

start-up companies. In addition, if the business opportunity qualifies, IE and RV can provide additional

funding up to a combined total of $1.25 million.

LAUNCH

NEW IN 2013

Analytic Diabetic Systems, LLC — Brent CameronAnalytic Diabetic Systems is a wholly owned subsidiary of Dayton, Ohio’s Aptima Inc., focused on deploying medical analytics specifically for predicting glucose in both inpatient and outpatient settings.

Butterfly Spine, LLC — Vijay Goel and Anand AgarwalButterfly Spine is dedicated to the discovery, development and commercialization of spinal products that are necessary to fuse a degenerated segment. Its current project is a novel interspinous dynamic fusion device in collaboration with Paradigm Spine.

EndoSphere Spine, LLC — Vijay Goel and Anand AgarwalEndoSphere Spine is a biotechnology company dedicated to the discovery, development and commercialization of a minimally-invasive endoscopic fusion cage that will be used to restore spinal alignment and fusion of a degenerated segment with minor soft tissue trauma.

2012

Imhoteq Biotechnology, LLC — Khew-Voon Chin Imhoteq Biotechnology is dedicated to developing and commercializing a cutting-edge portable biosensor system for testing halal/kosher foods to ensure authenticity and integrity for consumers in the global community of Jewish and Muslim populations.

Digital Therapeutics, LLC — Bashar M. KahalehDigital Therapeutics focuses on developing treatments for orphan diseases with high unmet medical need, focusing particularly on inflammation.

2011 AccuGenomics, LLC — James C. WilleyAccuGenomics provides comprehensive and accurate gene expression tests to diagnose, monitor and direct cancer treatment, and ensure confidence in clinical decisions.

Excellent Energy Solutions (ExEnSo) — Peter Kascak, Ralph Jansen and Timothy DeverExEnSo is developing an innovative flywheel energy storage system that may be used for distributed or centralized energy management. This proprietary system will be combined with enabling technological advances under joint development by ExEnSo, NASA and UT.

2010

Gamma Spine, Inc. — Vijay GoelThrough mathematical testing, Gamma Spine has developed a posterior lumbar disk replacement with a novel design. Once inserted during surgery, the device can be contracted and expanded, allowing surgery to be completed with less risk for spinal nerve root damage.

2009

Acense, LLC — Abdul-Majeed Azad Acense develops and tests sensors focused on early fault warning for oil-immersed electrical equipment.

2008

ADS Biotechnology, Ltd. — Joseph Shapiro, David Dignam and Ragheb Assaly ADS Biotechnology is developing a revolutionary approach for treating threatening clinical conditions. The company’s primary product, pegylated albumin, is a therapeutic colloid-type blood volume expander agent that is superior to human serum albumin.

Lucintech, Inc. — Al Compaan Lucintech is developing CdTe thin-film photovoltaics on polyimide substrates.

2007

SuGanit Systems — Sasidhar Varanasi, Connie Schall, Jared Anderson, Patricia Relue and Glen LipscombSuGanit Systems is involved in R&D of renewable and clean energy with a focus on ethanol production from biomass including algae.

2006

Xunlight Corporation — Xunming DengXunlight develops, markets and manufactures low-cost, thin-film, silicon-based photovoltaic products and manufacturing equipment for high-throughput production of flexible and lightweight photovoltaic modules.

Spinal Designs — Ashok BiyaniSpinal Designs provides products and services to orthopaedic surgeons.

Freedom Meditech — Brent CameronFreedom Meditech is a developmental stage medical device company focused on non-invasive blood glucose testing for diabetics.

2005

The Turning Point, LLC — Vijay Goel, Danny Pincivero, John Jaegly and David Dick The Turning Point produces state-of-the-art golf exercise and therapeutic devices for spine strengthening and rehabilitation.

2002

Mithridion — Wayne Hoss and William S. MesserMithridion is an emerging biotech company focused on the discovery and commercialization of treatments for neurological and psychiatric diseases.

2001

Schneider and Morse Group — Roy Schneider and Dennis MorseThe Schneider and Morse Group develops computer-based educational tools for animal anatomy and dissection.

Start-ups*

* Start-ups were established to commercialize technology developed by named faculty member(s).

Page 5: Cutting Edge of Research and Science ANNUAL REPORT ON ... 2013... · ANNUAL REPORT ON TECHNOLOGY TRANSFERFISCAL YEAR2013 Technology Transfer The process of transferring creations,

FY2013 Invention DisclosuresCENTER FOR CREATIVE INSTRUCTION Daniel Brainard, Brock Clagg, Eric Eitniear, Tonya Floyd-Bradstock, Roy Schneider, Sherry Andrews, Jamie Carothers and Lisa Procyk WebSim/Prep/Sim 101 Patient assessment tools for cardiac

and respiratoryDaniel Brainard, Brock Clagg, Tonya Floyd-Bradstock, Roy Schneider, Susan Shible, Sherry Andrews, Jamie Carothers, Lisa Procyk and Brian Szabo Anatomy and Physiology Revealed: Cat

INFORMATION OPERATIONS TECHNOLOGY MANAGEMENTJeffrey Coyne UTAD printer automation

JUDITH HERB COLLEGE OF EDUCATION, HEALTH SCIENCE AND HUMAN SERVICEEarly Childhood, Physical and Special EducationCharlene Czerniak, Joan Kaderavek, Geoff Milewski, Tamala North and Regina Rotshtein Teacher assessment tool: The Systematic Coding of Inquiry Instruction

in Early learning Classrooms (SCIIENCE)

Rehabilitation Sciences Martin Rice RAPB-Random assignment with permutated blocks

COLLEGE OF ENGINEERINGBioengineeringNathaniel Westphal, Jennifer Guilford, Matthew Stasa and Marcus Sinewe Automated body fluid measurement systemEmily Breitner, Kristopher Rager, Matthew Rottinger and Frank Wagoner, Jr. Instachill instant cold packAakash Agarwal, Anand Agarwal, David Dick and Vijay Goel Interbody fusion device for minimally invasive implantationHang Shao, Agasteswar Vadiamani, and Patricia Relue Enzymatic digestion of microalgal biomass for lipid, sugar

and protein recoveryAnand Agarwal, David Dick and Vijay Goel Revised bioactive facet and pars fixation deviceAnand Agarwal and Vijay Goel Biosensor — Device to detect infection in real time

Novel shape memory polymer intervertebral cage design

Injectable biodegradable bone matrix for multiple myeloma lesion augmentation and osteoporosisAnand Agarwal, Vijay Goel, John D’Onofrio, Nathaniel Dubois, Jared Pack and David Taylor Stabilized spinal hook implantAnand Agarwal, Vijay Goel and Eda Yildirim Injectable nanofibrous stem cell-contained bone substitute for

fracture augmentationAnand Agarwal, Vijay Goel and Huan Zhou Production of bone cement and bioglass from egg shellsHuan Zhou Rare-earth containing biodegradable nanocrystalline magnesium alloys

for implant applications

Brent Cameron and Brandon Clarke Single crystal integrated magneto-optic modulator and compensatorHoangha Dao, Nicholas Liber and Scott Molitor Teacher assessment tool: The Systematic Coding of Inquiry Instruction

in Early learning Classrooms (SCIIENCE)Nathan Reaver Process and design for uptake of nutrients in agricultural drainage water

by native plant species used to produce biofuel and agricultural fertilizerVijay Goel Head restraint for automobile seatsVijay Goel and David Dick Core Axis

Chemical and Environmental EngineeringHamid Feyzizamagh, Dong-Shik Kim and Do-Young Yoon Biosensor — Device to detect infection in real timeDong-Shik Kim Injectable biodegradable bone matrix for multiple myeloma lesion

augmentation and osteoporosis Novel neurotrophic agents, LA-GAGR, and mini-GAGR Flow-induced electromagnetic anti-fouling technology

(FI-EMAF Technology)Sasidhar Varanasi and Sridhar Viamajala Enzymatic digestion of microalgal biomass for lipid, sugar

and protein recovery

Civil EngineeringYoungwoo Seo Flow-induced electromagnetic anti-fouling technology

(FI-EMAF Technology)Ryan McKibben Sustainable regional waste management facility Chirjiv Anand, Defne Apul, Jay Devkota and Hannah Schlachter Economic and environmental analysis of sanitation technologies

(EEAST) beta version

Economic and environmental analysis of sanitation technologies (EEAST) manual

Defne Apul and Jay Devkota Tools for evaluation of rainwater harvesting systems R2P2 report

Economic and environmental analysis of sanitation technologies (EEAST) associated videos

Electrical Engineering and Computer SciencesThomas Stuart High voltage system using PV windows to power fluorescent lighting

Simplified Mppt controller for PV panels

Maximum power point tracker (MPPT) to interface Building Integrated Photovoltaics (Bipv) to DC fluorescent lighting

Andrew Polasko and Michael Lumbrezer E-waste receptacle

Engineering TechnologyTom Burden Aircraft safety matsDavid Lillibridge Water/fire detection and notification systemKurt Schilling, Carolyn Damo, Jennifer Haupricht and Andrew Bruno Nause-a-wayEamon Kelley, Derek Deland and David Lillibridge Toilet overflow shut-off

Mechanical, Industrial and Manufacturing Engineering (MIME)John Setlock Generation of high pressure oxygen via electrochemical pumping in a

multi-stage electrolysis stack Garrett Rayman, John Leis, Alexander Ritzenthaler, Revillo Stevens and David Schroeder Pivot arm for ability to foot/hand pedal on bicycle trailerPaul Lawson Windshield washer fluid alternativeAhalapitiya Jayatissa Bone graft substitute materialSarit Bhaduri Production of bone cement and bioglass from egg shell

Rare-earth containing biodegradable nanocrystalline magnesium alloys for implant applications

Masking the bitter taste of lidocaine LCI injectable formulation for dental procedures

Novel shape memory polymer intervertebral cage design

Injectable biodegradable bone matrix for multiple myeloma lesion augmentation and osteoporosis

Sarit Bhaduri, Raymond Wetzel, Scott Rawlings and Jason Andler Tie CaddyJoseph Pequignot, Benjamin Sekas, Anthony Cherol, Alexander Stogran, Richard Mescher, Justin Yackee, Christopher Harris and Lesley Berhan EcoSmart Bus BenchMatthew Franchetti, Connor Kress, David Levanduski, Alec Broyles, Jacob West and John Hart Ferro Fluid Electromagnet Plastic Particle SeparatorMohammad Elahinia and Milad Hosseinipour Intra-ventricular assistive device for end-stage cardiac patients Liberty Deberg, Mohammad Elahinia, Masood Taheri and Milad Hosseinipour Shape memory alloy ankle foot orthosis for addressing drop footMohammad Elahinia and Mohammadhassan Sofla Optimum prosthetic and orthotic design concept, method and softwareMohammad Elahinia and Phillip White Mitigating concussion: An innovative football helmetMohammed Hefzy, Adam Dellinger, Chao Xue, Benjamin Zellers and Mehdi Pourazady Air ChairPhillip White, Thomas Bruecker, Matthew Curcio, James Forrester, Josh Hewitt, Jeremy Oroguany and Kyle Pitchler Automated beverage bottle opener Yong Gan, Paul Lawson, Andrew Moening, Omar Mohammed and Matthew Haubert Biophoto fuel cell

COLLEGE OF LANGUAGES, LITERATURE AND SOCIAL SCIENCESGeography and PlanningCathy Schaffer Behavior Therapy App

COLLEGE OF MEDICINE AND LIFE SCIENCESBiochemistry and Cancer BiologyCynthia Smas RIFL as a regulator of lipid metabolism in humansIvana de la Serna and Archit Trivedi Method for modulating pigmentation by targeting BET bromodomain proteinsStephan Patrick Inhibitors of ERCC1-XPF

Dentistry Michael Nedley Masking the bitter taste of lidocaine LCI injectable formulation for

dental procedures

MedicineThomas Blomquist, Erin Crawford and James Willey Standardized RNA sequencing (Starseq)

Standardized RNA sequencing (Starseq) IIErin Crawford, James Willey and Jiyoun Yeo Two-color real-time PCR methods that enable quality-controlled molecular

diagnostic test in FFPE samples

NeurosciencesJoshua Park Novel neurotrophic agents, LA-GAGR, midi-GAGR, and mini-GAGR

Operating RoomGregory A. Cook Tie Caddy

Orthopaedic SurgeryAmbalangodage Champa Jayasuriya Bone graft substitute material

PathologyKenneth Hensley Semaphorin-blocking antibodies to treat motor neuron disease Novel neurotrophic agents, LA-GAGR, midi-GAGR and mini-GAGR

Physiology and PharmacologyNader Abraham, Bruce Heck and DongHyun Kim EET (Epoxyeicosatreienoic acid), Antagonist and agonists in the treatment of

osteoarthritis, osteoporosis, metabolic bone disease and fracture management

PPAR & Delta (Peroxisome-Proliferator-activated receptor & delta) antagonist and agonists in the treatment of osteoporosis, osteoarthritis, metabolic bone disease and fracture management

Bruce Heck and DongHyun Kim 20-OH-PGE2 analogues and EET analogues in the treatment of osteoarthritis,

osteoporosis, metabolic bone disease and fracture management

SurgeryAndrea Kalinoski Nanostructured mists for targeting compounds into the lungsReginald Baugh History of present illness trainerThomas Schwann Automated body fluid measurement system

Page 6: Cutting Edge of Research and Science ANNUAL REPORT ON ... 2013... · ANNUAL REPORT ON TECHNOLOGY TRANSFERFISCAL YEAR2013 Technology Transfer The process of transferring creations,

UrologyMichael Rees Kidney paired donation combination assessment rather than immediate

optimization

Process to identify critical costs and strategies to reduce these costs in complex medical conditions for health-care organizations

Reverse-transplant tourism

Combining desensitization and kidney paired donation to achieve kidney transplantation

International kidney paired donation as a means to recruit international patients to America

Bradley Buck and Stephen Selman Syllabus for student on urology rotation

COLLEGE OF NATURAL SCIENCES AND MATHEMATICS

Biological SciencesAnthony Quinn BBR3378 mediated regulation of autoimmune diseaseWilliam Taylor New class of highly selective anticancer agents targeting non-small

cell lung cancer Boren Lin Biosensor — Device to detect infection in real time Injectable biodegradable bone matrix for multiple myeloma lesion

augmentation and osteoporosisLirim Shemshedini A-8r peptide derivatives

ChemistryLorenza Favrot and Donald Ronning Method for inhibiting the enzymatic activity of enzymes encoded by the

fbp genes of actinobacteria Terry Bigioni, Brian Conn and Ahil Desireddy Method to synthesize pure Ag44(Sr)30m4 cluster molecules Pure Ag44(Sr)30m4 cluster moleculesEric Findsen, Dragan Isailovic, Zhen Sun and Raymond West Atmosphere pressure visible-wavelength MALDI-MSDean Giolando Alumina coating on plastic article to impact abrasion resistance

Transparent conducting oxides coatings prepared at high temperaturesDean Giolando and Ahmad Taha Robust tin oxide coated triple junction solar cells

Environmental SciencesDaryl Dwyer and Kristopher Barnswell Process and design for uptake of nutrients in agricultural drainage water

by native plant species used to produce biofuel and agricultural fertilizer

Physics and AstronomyAlvin Compaan, Michael Heben, Rajendra Khanal and Adam Phillips Copper-free back contact for CdTe solar cell devicesRandall Ellingson, Michael Heben and Anthony Vasko Solar window with built-in electrical system

Carbon nanotube/metal grid transparent and conducting layer for photovoltaics and other applications

Alvin Compaan, Hasitha Mahabaduge, Victor Plotnikov and Kristopher Wieland Front interfacial layer to improve Cdte-based cell performance

COLLEGE OF NURSINGCenter for Continuing Nursing EducationDeborah Mattin WebSim/Prep/Sim 101 Patient assessment tools for cardiac and

respiratory

COLLEGE OF PHARMACY AND PHARMACEUTICAL SCIENCES

Medicinal and Biological ChemistrySara Fedorka and Liyanaaratchige Tillekeratne New class of highly selective anticancer agents targeting non-small

cell lung cancer Paul Erhardt Inhibitors of ERCC1-XPF 20-OH-PGE2 analogues and EET analogues in the treatment of

osteoarthritis, osteoporosis, metabolic bone disease and fracture management

Paul Erhardt and Neha Malik Synthesis of 6a-Hydroxypterocarpans via intramolecular benzoin

condensation

PharmacologyFrederick Williams Nanostructured mists for targeting compounds into the lungsMiles Hacker BBR3378 mediated regulation of autoimmune disease Youssef Sari MS-153 as a drug for the treatment of alcohol dependence

Pharmacy PracticeSai Boddu Masking the bitter taste of lidocaine LCI injectable formulation for

dental proceduresXiaodong (Robert) Wang Design, synthesis and studies of small molecules for cystic fibrosisSai Boddu, Jerry Nesamony and Ashish Kaira Nanostructured mists for targeting compounds into the lungs

UTMC

Cardiac RehabilitationDalynn Badenhop, Stephanie Mousoulias and Catherine Roberts The University of Toledo Medical Center Cardiac Rehabilitation Individual

Treatment PlanFamily MedicineRadha Ramana Gokula Effect of chia seeds on hydration; development of a food beverage

GERIALYTE/CHIALYTE

PharmacyValerie Householder, Geoffrey Mospan and Cindy Puffer Rxpectations MTM (Medication Therapy Management)

Patents!The University of Toledo would like to recognize the following inventors’ contributions in promoting the progress of science through designation as an inventor on one or more patent grants. Names in gold are inventors who contributed to patents that were issued in fiscal year 2013. UT has been issued more than 185 U.S. patents since 1972.

Mamoun Alhamadsheh

Richard Andaloro

Donald Angelbeck

Bernard Arulanandam

Ragheb Assaly

Bradley Austermiller

Abdul-Majeed Azad

Kenneth Bachmann

James Baril

Ashok Biyani

Gloria Borgstahl

Michael Brattain

Renee Buchanan

Jeffrey Burnham

James Byers

Brent Cameron

Yang Cao

Keming Chen

Xia Chen

Jiqi Cheng

Garry Cole

Alvin Compaan

Erin Crawford

Anantha Dadi

Julian Davies

Robert Deck

Laurent Deloux

Jeffery DeMuth

Xunming Deng

David Dick

John Dignam

Philip Dunbar

Graham Durant

Sylvain Dutremez

Paul Erhardt

Ervin Faulmann

John Feldmeier

Ronald Fournier

Peter Fraleigh

James Fry

Kuan-Chen Fu

James Gano

Greta Garbo

Dean Giolando

Vijay Goel

Peter Goldblatt

Stephen Goldman

Bing Gong

Anne Graves

Akhlesh Gupta

Jiwan Gupta

George Hageage

James Hampton

Gregory Haselhuhn

Judy Hendricks

Channing Hinman

James Horner

Wayne Hoss

Xuefei Huang

Richard Hudson

Chiung-Yu Hung

James Huttner

Clara Jackson

John Jaegly

Douglas Jambard-Sweet

Jerzy Jankun

Ralph Jansen

Ahalapitiya Jayatissa

Victor Karpov

Stamatios Kartalopoulos

Peter Kascak

Rick Keck

Amin Khan

Roger King

Jon Kirchhoff

Thoe Kirkland III

Rita Klein

Wieslaw Klis

Charles Knight

Steven Kramer

Kenneth Kropp

Frederick Kurtz

Harold Lee

Aklilu Lemma

Marc Levine

Xianbo Liao

Jeffrey Lovelace

Jian-Yu Lu

Rosa Lukaszew

Edward Lumsdaine

Xianda Ma

Parani Madasamy

Konstantin Makhratchev

Maurice Manning

William Messer Jr.

Dennis Metzger

Alan Morgan

Naser Mostaghel

D’Anna Mullins

Durgesh Nadkarni

Ganapathy Naganathan

Terry Ng

Babatunde Ojo

Ishmael Parsai

Danny Pincivero

Henry Povolny

Kent Price

Demetrios Raftopoulos

Walajapet Rajeswaran

Glenn Reimer

William Roll

Yann Roussillon

Sairam Rudrabhatla

Jeffrey Sabin

Murray Saffran

Jeffrey Sarver

Connie Schall

Padmanabhan Sekher

Steven Selman

Kalpathi Seshan

Joseph Shapiro

Diana Shvydka

Henry Simon

Dimitris Skalkos

Ewa Skrzypczak-Jankun

James Slama

Clifford Smith

Edward Snell

Morris Srebnik

Sujatha Srinivasan

Thomas Stuart

Desikan Sundararajan

Verner Swanson

Sridhar Thirupathi

Jiang Tian

Liyanaaratchige Tillekeratne

James Trempe

Stefan Uhlenbrock

Sasidhar Varanasi

Yu Wang

David Weaver

James Willey

Zi-Jian Xie

Liwei Xu

Jianmin Xue

Qicheng Yang

Zhong Ye

Jieh-Juen Yu

Quilin Yu

Bin Zheng

Donald Zrudsky

u t o l e d o . e d u / r e s e a r c h / t e c h t r a n s f e r

Page 7: Cutting Edge of Research and Science ANNUAL REPORT ON ... 2013... · ANNUAL REPORT ON TECHNOLOGY TRANSFERFISCAL YEAR2013 Technology Transfer The process of transferring creations,

Our mission 1. Support UT’s mission to improve the human condition;

2. Provide accessible, responsive, competent, timely, and professional patenting and licensing services to UTs faculty, staff and students;

3. Serve as an efficient and effective conduit for licensing promising UT technologies to industry to promote their entry into the commercial marketplace and:

• Attract and retain the highest quality faculty and students • Increase and expand UT’s research enterprise • Create and reinforce commercial relationships • Generate institutional acclaim and recognition, and • Provide an additional revenue stream

4. Support and encourage local economic development by licensing locally, by licensing to start-up companies, by favoring licenses to faculty start-up companies, and by encouraging and supporting faculty start-up activities;

5. Serve as a resource for information about patents and licensing and encourage recognition that such matters have become meaningful and valuable aspects of academic life and education; and

6. Facilitate greater integration and increased sponsored research activity between academia and industry to improve the flow of innovative university technologies to the public marketplace.

Stephen Snider, JD

Associate Vice President for Technology Transfer

Associate General Counsel

419.530.6225

[email protected]

Mark Fox, MS, JD

Patent Technology Associate

419.530.6229

[email protected]

Anne Izzi, JD

Licensing Associate

419.530.6226

[email protected]

Abhishek Sangal, MS, MBA

Licensing Associate

419.530.6231

[email protected]

Sandra Rhoades

IP Administrator

419.530.6224

[email protected]

Contact Us

u t o l e d o . e d u / r e s e a r c h / t e c h t r a n s f e r